Modulatory role of angiotensin-II in the secretion of atrial natriuretic factor in rabbits

Massimo Volpe, Paolo Pepino, Giuseppe Lembo, Silvana Pignalosa, Alessandro F. Mele, Speranza Rubattu, Gianluigi Condorelli, Elvio Covino, Bruno Trimarco

Research output: Contribution to journalArticle

Abstract

This study was designed to investigate whether the increase in circulating atrial natriuretic factor (ANF) levels produced by angiotensin II (Ang II) is a consequence of the hemodynamic changes or whether it occurs also in the absence of pressor changes. For this purpose in anesthetized and awake rabbits we evaluated the effects of Ang II (0.1 μg/kg·min) alone or during the simultaneous infusion of sodium nitroprusside (NP) at a dose titrated to abolish the pressor effects. Systemic blood pressure increased from 76 ± 4 to 113 ± 5 mm Hg (P <0.001) during Ang II and from 76 ± 2 to 75 ± 3 mm Hg (P = NS) during Ang II plus NP. The α-adrenergic agonist phenylephrine, used as a control, raised blood pressure from 65 ± 2 to 101 ± 8 mm Hg (P <0.001), and its pressor effect was abolished by the concomitant infusion of NP (64 ± 2 to 61 ± 1 mm Hg; P = NS). The increase in plasma ANF levels produced by Ang II alone (from 36.5 ± 5 to 237 ± 57 pg/ml; P <0.001) was not different from that observed during Ang II plus NP (from 46 ± 10 to 207 ± 88 pg/ml; P <0.001). In contrast, the stimulatory effect on ANF release of phenylephrine (from 56.1 ± 9 to 202 ± 40 pg/ml; P <0.001) was completely abolished when its pressor effects were prevented by the combined infusion of NP (from 58.5 ± 15 to 42.3 ± 10 pg/ml; P = NS). These results show that the stimulatory effect of Ang II on ANF release can be clearly dissociated from its pressor effect, whereas the increase in plasma ANF levels caused by phenylephrine is strictly related to its hemodynamic effect. Therefore, Ang II is capable of modulating ANF secretion in a manner that is independent of its pressor actions. In addition, our results suggest that ANF release is not solely linked to myocyte stretch.

Original languageEnglish
Pages (from-to)2427-2431
Number of pages5
JournalEndocrinology
Volume128
Issue number5
Publication statusPublished - May 1991

Fingerprint

Atrial Natriuretic Factor
Angiotensin II
Rabbits
Nitroprusside
Phenylephrine
Hemodynamics
Blood Pressure
Adrenergic Agonists
Muscle Cells

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Modulatory role of angiotensin-II in the secretion of atrial natriuretic factor in rabbits. / Volpe, Massimo; Pepino, Paolo; Lembo, Giuseppe; Pignalosa, Silvana; Mele, Alessandro F.; Rubattu, Speranza; Condorelli, Gianluigi; Covino, Elvio; Trimarco, Bruno.

In: Endocrinology, Vol. 128, No. 5, 05.1991, p. 2427-2431.

Research output: Contribution to journalArticle

Volpe, M, Pepino, P, Lembo, G, Pignalosa, S, Mele, AF, Rubattu, S, Condorelli, G, Covino, E & Trimarco, B 1991, 'Modulatory role of angiotensin-II in the secretion of atrial natriuretic factor in rabbits', Endocrinology, vol. 128, no. 5, pp. 2427-2431.
Volpe, Massimo ; Pepino, Paolo ; Lembo, Giuseppe ; Pignalosa, Silvana ; Mele, Alessandro F. ; Rubattu, Speranza ; Condorelli, Gianluigi ; Covino, Elvio ; Trimarco, Bruno. / Modulatory role of angiotensin-II in the secretion of atrial natriuretic factor in rabbits. In: Endocrinology. 1991 ; Vol. 128, No. 5. pp. 2427-2431.
@article{58a3068219c54cfd9f56911cd0596075,
title = "Modulatory role of angiotensin-II in the secretion of atrial natriuretic factor in rabbits",
abstract = "This study was designed to investigate whether the increase in circulating atrial natriuretic factor (ANF) levels produced by angiotensin II (Ang II) is a consequence of the hemodynamic changes or whether it occurs also in the absence of pressor changes. For this purpose in anesthetized and awake rabbits we evaluated the effects of Ang II (0.1 μg/kg·min) alone or during the simultaneous infusion of sodium nitroprusside (NP) at a dose titrated to abolish the pressor effects. Systemic blood pressure increased from 76 ± 4 to 113 ± 5 mm Hg (P <0.001) during Ang II and from 76 ± 2 to 75 ± 3 mm Hg (P = NS) during Ang II plus NP. The α-adrenergic agonist phenylephrine, used as a control, raised blood pressure from 65 ± 2 to 101 ± 8 mm Hg (P <0.001), and its pressor effect was abolished by the concomitant infusion of NP (64 ± 2 to 61 ± 1 mm Hg; P = NS). The increase in plasma ANF levels produced by Ang II alone (from 36.5 ± 5 to 237 ± 57 pg/ml; P <0.001) was not different from that observed during Ang II plus NP (from 46 ± 10 to 207 ± 88 pg/ml; P <0.001). In contrast, the stimulatory effect on ANF release of phenylephrine (from 56.1 ± 9 to 202 ± 40 pg/ml; P <0.001) was completely abolished when its pressor effects were prevented by the combined infusion of NP (from 58.5 ± 15 to 42.3 ± 10 pg/ml; P = NS). These results show that the stimulatory effect of Ang II on ANF release can be clearly dissociated from its pressor effect, whereas the increase in plasma ANF levels caused by phenylephrine is strictly related to its hemodynamic effect. Therefore, Ang II is capable of modulating ANF secretion in a manner that is independent of its pressor actions. In addition, our results suggest that ANF release is not solely linked to myocyte stretch.",
author = "Massimo Volpe and Paolo Pepino and Giuseppe Lembo and Silvana Pignalosa and Mele, {Alessandro F.} and Speranza Rubattu and Gianluigi Condorelli and Elvio Covino and Bruno Trimarco",
year = "1991",
month = "5",
language = "English",
volume = "128",
pages = "2427--2431",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Modulatory role of angiotensin-II in the secretion of atrial natriuretic factor in rabbits

AU - Volpe, Massimo

AU - Pepino, Paolo

AU - Lembo, Giuseppe

AU - Pignalosa, Silvana

AU - Mele, Alessandro F.

AU - Rubattu, Speranza

AU - Condorelli, Gianluigi

AU - Covino, Elvio

AU - Trimarco, Bruno

PY - 1991/5

Y1 - 1991/5

N2 - This study was designed to investigate whether the increase in circulating atrial natriuretic factor (ANF) levels produced by angiotensin II (Ang II) is a consequence of the hemodynamic changes or whether it occurs also in the absence of pressor changes. For this purpose in anesthetized and awake rabbits we evaluated the effects of Ang II (0.1 μg/kg·min) alone or during the simultaneous infusion of sodium nitroprusside (NP) at a dose titrated to abolish the pressor effects. Systemic blood pressure increased from 76 ± 4 to 113 ± 5 mm Hg (P <0.001) during Ang II and from 76 ± 2 to 75 ± 3 mm Hg (P = NS) during Ang II plus NP. The α-adrenergic agonist phenylephrine, used as a control, raised blood pressure from 65 ± 2 to 101 ± 8 mm Hg (P <0.001), and its pressor effect was abolished by the concomitant infusion of NP (64 ± 2 to 61 ± 1 mm Hg; P = NS). The increase in plasma ANF levels produced by Ang II alone (from 36.5 ± 5 to 237 ± 57 pg/ml; P <0.001) was not different from that observed during Ang II plus NP (from 46 ± 10 to 207 ± 88 pg/ml; P <0.001). In contrast, the stimulatory effect on ANF release of phenylephrine (from 56.1 ± 9 to 202 ± 40 pg/ml; P <0.001) was completely abolished when its pressor effects were prevented by the combined infusion of NP (from 58.5 ± 15 to 42.3 ± 10 pg/ml; P = NS). These results show that the stimulatory effect of Ang II on ANF release can be clearly dissociated from its pressor effect, whereas the increase in plasma ANF levels caused by phenylephrine is strictly related to its hemodynamic effect. Therefore, Ang II is capable of modulating ANF secretion in a manner that is independent of its pressor actions. In addition, our results suggest that ANF release is not solely linked to myocyte stretch.

AB - This study was designed to investigate whether the increase in circulating atrial natriuretic factor (ANF) levels produced by angiotensin II (Ang II) is a consequence of the hemodynamic changes or whether it occurs also in the absence of pressor changes. For this purpose in anesthetized and awake rabbits we evaluated the effects of Ang II (0.1 μg/kg·min) alone or during the simultaneous infusion of sodium nitroprusside (NP) at a dose titrated to abolish the pressor effects. Systemic blood pressure increased from 76 ± 4 to 113 ± 5 mm Hg (P <0.001) during Ang II and from 76 ± 2 to 75 ± 3 mm Hg (P = NS) during Ang II plus NP. The α-adrenergic agonist phenylephrine, used as a control, raised blood pressure from 65 ± 2 to 101 ± 8 mm Hg (P <0.001), and its pressor effect was abolished by the concomitant infusion of NP (64 ± 2 to 61 ± 1 mm Hg; P = NS). The increase in plasma ANF levels produced by Ang II alone (from 36.5 ± 5 to 237 ± 57 pg/ml; P <0.001) was not different from that observed during Ang II plus NP (from 46 ± 10 to 207 ± 88 pg/ml; P <0.001). In contrast, the stimulatory effect on ANF release of phenylephrine (from 56.1 ± 9 to 202 ± 40 pg/ml; P <0.001) was completely abolished when its pressor effects were prevented by the combined infusion of NP (from 58.5 ± 15 to 42.3 ± 10 pg/ml; P = NS). These results show that the stimulatory effect of Ang II on ANF release can be clearly dissociated from its pressor effect, whereas the increase in plasma ANF levels caused by phenylephrine is strictly related to its hemodynamic effect. Therefore, Ang II is capable of modulating ANF secretion in a manner that is independent of its pressor actions. In addition, our results suggest that ANF release is not solely linked to myocyte stretch.

UR - http://www.scopus.com/inward/record.url?scp=0025876424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025876424&partnerID=8YFLogxK

M3 - Article

C2 - 1826877

AN - SCOPUS:0025876424

VL - 128

SP - 2427

EP - 2431

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 5

ER -